SERUM FIBRINOGEN IS MORE CLOSELY ASOCIATED WITH LONGER-TERM ISCHEMIC CARDIAC EVENTS AFTER PERCUTANEOUS CORONARY INTERVENTION THAN VERIFYNOW P2Y12 PLATELET REACTIVITY MEASUREMENTS

被引:0
|
作者
Enright, Kelly [1 ]
Ang, Lawrence [1 ]
Li, Shiqian [1 ]
Teh, Phildrich [1 ]
Huynh, Andrew [1 ]
Ramsis, Mattheus [1 ]
Taqui, Sahar [1 ]
Palakodeti, Samhita [1 ]
Lin, Felice [1 ]
Patel, Mitul [1 ]
Reeves, Ryan [1 ]
Mahmud, Ehtisham [1 ]
机构
[1] Univ Calif San Diego, Med Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S0735-1097(14)60263-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1265-257
引用
收藏
页码:A263 / A263
页数:1
相关论文
共 45 条
  • [1] Correlation between Light Transmission Aggregometry, VerifyNow P2Y12, and VASP-P Platelet Reactivity Assays Following Percutaneous Coronary Intervention
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Pakala, Rajbabu
    Xue, Zhenyi
    Sardi, Gabriel
    Suddath, William O.
    Kent, Kenneth M.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2011, 24 (06) : 529 - 534
  • [2] Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention
    Ingraham, Brenden S.
    Farkouh, Michael E.
    Lennon, Ryan J.
    So, Derek
    Goodman, Shaun G.
    Geller, Nancy
    Bae, Jang-Ho
    Jeong, Myung Ho
    Baudhuin, Linnea M.
    Mathew, Verghese
    Bell, Malcolm R.
    Lerman, Amir
    Fu, Yi-Ping
    Hasan, Ahmed
    Iturriaga, Erin
    Tanguay, Jean-Francois
    Welsh, Robert C.
    Rosenberg, Yves
    Bailey, Kent
    Rihal, Charanjit
    Pereira, Naveen L.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (07) : 816 - 825
  • [3] Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Luo, Yu
    Li, Jimin
    Liu, Xu
    Xu, Jianfeng
    Ye, Zi
    Yao, Yian
    Liu, Xuebo
    Lai, Yan
    THROMBOSIS RESEARCH, 2016, 139 : 114 - 120
  • [4] Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial
    Price, Matthew J.
    Angiolillo, Dominick J.
    Teirstein, Paul S.
    Lillie, Elizabeth
    Manoukian, Steven V.
    Berger, Peter B.
    Tanguay, Jean-Francois
    Cannon, Christopher P.
    Topol, Eric J.
    CIRCULATION, 2011, 124 (10) : 1132 - 1137
  • [5] Differences in Optimal Platelet Reactivity after Potent P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
    Song, Kai
    Jin, Xuan
    Kim, Moo-Hyun
    Li, Jia-Xin
    Jin, Cai-De
    Yuan, Song-Lin
    Song, Zhao-Yan
    Jin, En-Ze
    Lee, Kwang-Min
    Lim, Kyung-Hee
    Cho, Young-Rak
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [6] De-Escalation of Platelet P2Y12 Receptor Inhibiting Therapy After Percutaneous Coronary Intervention
    Franchi, Francesco
    Rollini, Fabiana
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (24) : 2571 - 2573
  • [7] Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention
    Ahn, Sung Gyun
    Lee, Seung-Hwan
    Sung, Joong Kyung
    Kim, Jang-Young
    Yoon, Junghan
    PLATELETS, 2011, 22 (04) : 305 - 307
  • [8] Efficacy of Change to New P2Y12 Receptor Antagonists in Patients High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
    Robledo-Nolasco, Rogelio
    Godinez-Montes de Oca, A.
    Zaballa-Contreras, J. F.
    Suarez-Cuenca, J. A.
    Mondragon-Teran, P.
    Rubio-Guerra, A. F.
    Melendez-Alcantara, M. A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2015, 21 (07) : 619 - 625
  • [9] Response to Letters Regarding Article, "Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Time-Dependent Analysis of the Gauging Responsiveness With a VerifyNow P2Y12 Assay: Impact on Thrombosis and Safety (GRAVITAS) Trial"
    Price, Matthew J.
    Teirstein, Paul S.
    Topol, Eric J.
    Lillie, Elizabeth
    Manoukian, Steven V.
    Berger, Peter B.
    Tanguay, Jean-Francois
    Cannon, Christopher P.
    Angiolillo, Dominick J.
    CIRCULATION, 2012, 125 (14) : E571 - E572
  • [10] High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention
    Luis Ferreiro, Jose
    Vivas, David
    Maria De La Hera, Jesus
    Lucrecia Marcano, Ana
    Marisol Lugo, Leslie
    Carlos Gomez-Polo, Juan
    Silva, Iria
    Tello-Montoliu, Antonio
    Marin, Francisco
    Roldan, Inmaculada
    THROMBOSIS RESEARCH, 2019, 175 : 95 - 101